Unintentional weight loss (UWL) often presents a diagnostic challenge in clinical practice. It is a non-specific symptom associated with a wide range of conditions, from benign to life-threatening. This article aims to provide a comprehensive approach to evaluating unexplained weight loss in clinical practice.
Firstly, a thorough history and physical examination are crucial. This should include a detailed dietary history, medication review, and assessment of psychological factors. It is also important to consider the patient's age, as certain conditions such as malignancies are more common in older adults.
Basic laboratory investigations should include complete blood count, electrolyte panel, liver function tests, thyroid function tests, and urinalysis. Depending on the patient’s history and physical examination, more specific tests may be indicated, such as tumor markers or imaging studies.
In elderly patients, a common cause of UWL is the so-called "anorexia of aging," which is often multifactorial and includes decreased appetite, changes in taste and smell, and social factors. In these cases, a multidisciplinary approach involving dietitians, social workers, and possibly psychiatrists may be beneficial.
Patients with unexplained weight loss should be closely monitored. If initial investigations do not reveal a cause, consider repeating the investigations after a period of time or refer to a specialist. It is also important to monitor the patient's nutritional status and provide nutritional support if needed.
In conclusion, the evaluation of unexplained weight loss is a complex process that requires a systematic approach. A thorough history and physical examination, combined with targeted investigations, can help identify the underlying cause. Multidisciplinary involvement and close follow-up are also crucial in managing these patients.
1.
Trial Supports Ivonescimab and Chemo for NSCLC Survival
2.
Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.
3.
Lymph node transfer reduces arm swelling after breast cancer surgery, study shows
4.
Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.
5.
Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?
1.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
2.
Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options
3.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
4.
Uncovering the Mysteries of the RDW Blood Test
5.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part II
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Navigating the Complexities of Ph Negative ALL - Part XIV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation